Article

Two-year data promising for dual-optic accommodating IOL

The newer generation of a dual-optic accommodating IOL (Synchrony, Visiogen) is easy to implant, centers well, provides good distance visual acuity, and demonstrates good safety in terms of potential posterior capsule opacification development, according to H. Burkhard Dick, MD.

The newer generation of a dual-optic accommodating IOL (Synchrony, Visiogen) is easy to implant, centers well, provides gooddistance visual acuity, and demonstrates good safety in terms of potential posterior capsule opacification development,according to H. Burkhard Dick, MD.

Dr. Dick, professor of ophthalmology, Johannes-Gutenberg University, Mainz, Germany, discussed 2-year data related to hisexperience of implanting 30 of the silicone lenses, which have a high diopter anterior optic and a minus power posterioroptic, in a prospective trial of otherwise healthy eyes.

"The most important thing was preoperative counseling and biometrics," he said. "This included lens thickness evaluation."

Focus curve measurement showed that the IOL demonstrated accommodative amplitude in every patient, even after 2 years, Dr.Dick said. The mean was 1.5 to 1.75 D. Also, he said, no Nd:YAG capsulotomies have been required.

"All patients were very satisfied with the lens, and in terms of functionality, it was quite satisfying. Also, reading speedwas very sufficient," Dr. Dick said.

Because of its relatively large size, the IOL requires a relatively large incision for implantation, he said.

"My standard incision size is about 2.75 mm, but this is a thickness [where] you can't implant this lens," Dr. Dick said.

The lens has earned a CE Mark in Europe, he added.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.